Overall Winner: Alan·83/ 100

Alan vs Predible Health

In-depth comparison — valuation, funding, investors, founders & more

Winner
A
Alan

🇫🇷 France · Jean-Charles Samuelian

Series DAI HealthcareEst. 2016

Valuation

$1.4B

Total Funding

$220M

83
Awaira Score83/100

500-1000 employees

Full Alan Profile →
P
Predible Health

🇮🇳 India · Sanjoy Paul

Series AAI HealthcareEst. 2017

Valuation

N/A

Total Funding

$5M

50
Awaira Score50/100

10-50 employees

Full Predible Health Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Alan and Predible Health compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation.

Alan carries a known valuation of $1.4B, while Predible Health's valuation has not been publicly disclosed. On the funding side, Alan has raised $220M in total — $215M more than Predible Health's $5M.

Alan has 1 year more market experience, having been founded in 2016 compared to Predible Health's 2017 founding. In terms of growth stage, Alan is at Series D while Predible Health is at Series A — a meaningful difference for investors evaluating risk and upside.

Alan operates out of 🇫🇷 France while Predible Health is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Alan leads with a score of 83, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricAlanPredible Health
💰Valuation
$1.4B
N/A
📈Total Funding
$220MWINS
$5M
📅Founded
2016
2017WINS
🚀Stage
Series D
Series A
👥Employees
500-1000
10-50
🌍Country
France
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
83WINS
50

Key Differences

📈

Funding gap: Alan has raised $215M more ($220M vs $5M)

📅

Market experience: Alan has 1 year more (founded 2016 vs 2017)

🚀

Growth stage: Alan is at Series D vs Predible Health at Series A

👥

Team size: Alan has 500-1000 employees vs Predible Health's 10-50

🌍

Market base: 🇫🇷 Alan (France) vs 🇮🇳 Predible Health (India)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Alan scores 83/100 vs Predible Health's 50/100

Which Should You Choose?

Use these signals to make the right call

A

Choose Alan if…

Top Pick
  • Higher Awaira Score — 83/100 vs 50/100
  • More established by valuation ($1.4B)
  • Stronger investor backing — raised $220M
  • More market experience — founded in 2016
  • France-based for regional compliance or proximity
  • Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
P

Choose Predible Health if…

  • India-based for regional compliance or proximity
  • Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation

Users Also Compare

FAQ — Alan vs Predible Health

Is Alan bigger than Predible Health?
Alan has a disclosed valuation of $1.4B, while Predible Health's valuation is not publicly available, making a direct size comparison difficult. Alan employs 500-1000 people.
Which company raised more funding — Alan or Predible Health?
Alan has raised more in total funding at $220M, compared to Predible Health's $5M — a gap of $215M.
Which company has a higher Awaira Score?
Alan holds the higher Awaira Score at 83/100, compared to Predible Health's 50/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 33-point gap that reflects meaningful differences in scale or traction.
Who founded Alan vs Predible Health?
Alan was founded by Jean-Charles Samuelian in 2016. Predible Health was founded by Sanjoy Paul in 2017. Visit each company's profile on Awaira for a full founder biography.
What does Alan do vs Predible Health?
Alan: Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. The Paris company holds full insurance carrier status in France, Belgium, and Spain, operating as a licensed insurer rather than a distribution intermediary.\n\nThe company raised approximately $220 million including a Series D round from investors including Temasek, Coatue, and Index Ventures, reaching a valuation of approximately $1.4 billion. Alan reports over half a million members across its markets, covering employees at several thousand companies including Stripe, Spendesk, and Vinted, with strong growth in SME employer sales driven by its digital-first enrolment and claims experience. The Alan app provides members with health navigation, symptom checking, and AI-generated health content in addition to insurance card and claims management functionality.\n\nAlan competes in the European digital health insurance market against traditional mutuals including Malakoff Humanis and AG2R La Mondiale, as well as digital health insurers including Henner and Oscar Health in the US context. Its vertical integration as a licensed insurer combined with a technology platform differentiates it from insurtechs that distribute existing insurer products through digital channels, giving Alan full control over the member experience and claims economics. The company is considered one of the most significant French technology companies building in regulated financial services. Predible Health: Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. The platform integrates with radiology information systems and PACS to provide AI-assisted second reads and quantitative measurements that reduce reporting time and flag critical findings for urgent review.\n\nThe company raised approximately $5M in Series A funding and has established clinical partnerships with hospital networks and diagnostic imaging centers across India. Predible Health received significant validation through its COVID-19 CT analysis tool, which was deployed during the pandemic to help overwhelmed radiology departments manage surge volumes.\n\nRadiology AI represents one of the most commercially mature segments of medical AI globally, with clear clinical workflows, measurable radiologist productivity benefits, and established reimbursement pathways emerging in developed markets. Predible Health's India-focused deployments position it as a domestic alternative to global radiology AI companies, with the advantage of deep integration knowledge in Indian hospital IT environments.
Which company was founded first?
Alan was founded first in 2016, giving it 1 year of additional market experience. Predible Health was founded later in 2017. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Alan has approximately 500-1000 employees, while Predible Health has approximately 10-50. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Alan and Predible Health competitors?
Yes, Alan and Predible Health are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.